Literature DB >> 15112463

Structural MRI changes of the brain in depression.

Andres M Kanner1.   

Abstract

For many years, investigators have been trying to identify the neuroanatomical structures responsible for the development of neuropsychiatric disorders, specifically depression and schizophreniform disorders. The available data were based on observations made in neurological patients who developed a psychiatric comorbid disorder following the neurologic insult. With the advances in high-resolution magnetic resonance imaging and functional neuroimaging studies, we have witnessed in the last decade a wealth of new data that identify structural neuroimaging changes in mesial temporal structures, prefrontal cortex and basal ganglia in major depressive disorders. The purpose of this article is to briefly review the published data on neuroanatomical structural changes associated with major depressive and bipolar disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15112463     DOI: 10.1177/155005940403500111

Source DB:  PubMed          Journal:  Clin EEG Neurosci        ISSN: 1550-0594            Impact factor:   1.843


  10 in total

Review 1.  Toward dysfunctional connectivity: a review of neuroimaging findings in pediatric major depressive disorder.

Authors:  Leslie A Hulvershorn; Kathryn Cullen; Amit Anand
Journal:  Brain Imaging Behav       Date:  2011-12       Impact factor: 3.978

2.  Neuroplasticity in depressed individuals compared with healthy controls.

Authors:  Michael J Player; Janet L Taylor; Cynthia Shannon Weickert; Angelo Alonzo; Perminder Sachdev; Donel Martin; Philip B Mitchell; Colleen K Loo
Journal:  Neuropsychopharmacology       Date:  2013-05-16       Impact factor: 7.853

Review 3.  Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets.

Authors:  Paul J Carlson; Jaskaran B Singh; Carlos A Zarate; Wayne C Drevets; Husseini K Manji
Journal:  NeuroRx       Date:  2006-01

4.  Brainstem raphe lesion in patients with major depressive disorder and in patients with suicidal ideation recorded on transcranial sonography.

Authors:  Mislav Budisic; Budisic Mislav; Dalibor Karlovic; Karlovic Dalibor; Zlatko Trkanjec; Trkanjec Zlatko; Arijana Lovrencic-Huzjan; Lovrencic-Huzjan Arijana; Vlasta Vukovic; Vukovic Vlasta; Jelena Bosnjak; Bosnjak Jelena; Vida Demarin; Demarin Vida
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-09-15       Impact factor: 5.270

Review 5.  Identifying functional neuroimaging biomarkers of bipolar disorder: toward DSM-V.

Authors:  Mary L Phillips; Eduard Vieta
Journal:  Schizophr Bull       Date:  2007-06-11       Impact factor: 9.306

6.  Structural brain abnormalities in patients with psychogenic nonepileptic seizures.

Authors:  Ali A Asadi-Pooya; Maryam Homayoun
Journal:  Neurol Sci       Date:  2019-11-12       Impact factor: 3.307

7.  Why we still don't understand the depressed brain - Not going beyond snapshots.

Authors:  Henrik Kessler; Harald Traue; Daniel Wiswede
Journal:  Psychosoc Med       Date:  2011-09-23

8.  Abnormal Anterior Cingulate N-Acetylaspartate and Executive Functioning in Treatment-Resistant Depression After rTMS Therapy.

Authors:  Huirong Zheng; Fujun Jia; Guangquan Guo; Dongming Quan; Gang Li; Huawang Wu; Bin Zhang; Changhe Fan; Xiajun He; Huiyan Huang
Journal:  Int J Neuropsychopharmacol       Date:  2015-05-29       Impact factor: 5.176

9.  Maternal cafeteria diet exposure primes depression-like behavior in the offspring evoking lower brain volume related to changes in synaptic terminals and gliosis.

Authors:  Luis A Trujillo-Villarreal; Viktor J Romero-Díaz; Iván Alberto Marino-Martínez; Lizeth Fuentes-Mera; Marco Antonio Ponce-Camacho; Gabriel A Devenyi; M Mallar Chakravarty; Alberto Camacho-Morales; Eduardo E Garza-Villarreal
Journal:  Transl Psychiatry       Date:  2021-01-14       Impact factor: 6.222

10.  Tianeptine: an antidepressant with memory-protective properties.

Authors:  Phillip R Zoladz; Collin R Park; Carmen Muñoz; Monika Fleshner; David M Diamond
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.